Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Akouos Inc is a biotechnology business based in the US. Akouos Inc shares (AKUS) are listed on the NASDAQ and all prices are listed in US Dollars. Akouos Inc employs 103 staff and has a market cap (total outstanding shares value) of 0.00.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $4.44 |
|---|---|
| 52-week range | $2.32 - $13.69 |
| 50-day moving average | $3.50 |
| 200-day moving average | $4.76 |
| Wall St. target price | $20.50 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.83 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $4.44 from 2022-09-23
| 1 week (2022-09-16) | -13.95% |
|---|---|
| 1 month (2022-08-22) | 30.21% |
| 3 months (2022-06-23) | 5.46% |
| 6 months (2022-03-23) | -3.06% |
| 1 year (2021-09-24) | -65.47% |
|---|---|
| 2 years (2020-09-24) | -80.65% |
| 3 years (2019-09-20) | N/A |
| 5 years (2017-09-20) | N/A |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -21.37% |
| Return on equity TTM | -40.32% |
| Profit margin | 0% |
| Book value | $5.37 |
| Market capitalisation | $190.4 million |
TTM: trailing 12 months
We're not expecting Akouos Inc to pay a dividend over the next 12 months.
Over the last 12 months, Akouos Inc's shares have ranged in value from as little as $2.315 up to $13.69. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akouos Inc's is -0.0971. This would suggest that Akouos Inc's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Akouos Inc has bucked the trend.
Akouos, Inc. , a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. The company was incorporated in 2016 and is based in Boston, Massachusetts.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
We’ve rounded up stats on some of the most popular wheat stocks, along with information on how these stocks compare and how to invest.